Brecht Vanneste, associate VP and managing director of MSD in Belgium and Luxembourg, highlights the strategic significance of the affiliate as an important location for early-stage clinical trials and home to the company’s Heist-op-den-Berg production facility, a key manufacturing site for the global group. Vanneste delivers a strong message about the company’s aim to partner with local health authorities to ensure that local patients have continued access to innovation.
Thanks to our strong clinical network, a vast majority of our early discovery that happens across the globe is sent through Belgium
